lymphomas, chronic leukemia, and multiple myeloma; author and coauthor of over 170 peer -reviewed scientific papers and numerous book chapters; scientific editor of 4 books; principal investigator in over 35 clinical trials in oncology and hematology; recipient of multiple awards of the Rector of the Medical University of Warsaw and Minister of Health; decorated with Bronze and Gold Crosses of Merit and the Silver Medal for Long Service of the HCC progression and not cardiovascular complications. The examples like this are many.
Other numerous examples from my doctor's practice lead me to a conclusion that the clinical oncology specialty should include the credit obtained upon the completion of the basic internal medicine module, based on the theoretical and practical examination for example at those centers where the basic module would be completed. In this way we could raise the level of knowledge and professional competency among young doctors who are embarking on a difficult oncology path, without prolonging the duration of the specialization process itself.
As opposed to oncology, which in Poland has been functioning mainly through the regional oncology centers as of 1970s, hematology has always been connected to the university and multidisciplinary hospitals and the hematology wards were usually created from the transformed internal medicine wards. Before the introduction of the modular system, the hematology specialty commenced after the obtaining of the diploma of an internal medicine specialist. In the case of hematologists the knowledge and skills pertaining to internal medicine were therefore confirmed by the successful completion of a national examination and consolidated by the clinical practice at multidisciplinary hospitals, which meant that an average hematology specialist had more internist experience than an average oncologist. Once the modular specialty system was introduced, hematology was moved to a 2-module system including a basic module and a specialist module. And similarly to the clinical oncology specialty, the progression from the basic to the specialist module is not regulated by the requirement for a doctor participating in the specialty training to confirm his or her knowledge through the examination process. Therefore, I fear that in the future we will observe the decrease of the level of internist knowledge and the professional preparation of doctors commencing their hematology specialty. It seems only justified to me that the hematology specialty include the credit obtained upon the completion of the basic internal medicine module, based on the theoretical and practical examination for example at those centers where the basic module would be completed. To those who are skeptical I can only say that the doctors will not lose and the patients will gain.
The Polish society is aging, it is a known fact. The aging society gets sick more often and is affected by a larger number of diseases. Hence, the society needs more doctors who will have comprehensive medical knowledge and this group undoubtedly includes internal medicine specialists. An internal medicine specialist is perfectly prepared professionally to provide medical care to senior patients, and in my opinion equally well as a geriatric medicine specialist. If we were to adopt this kind of solution, an internal medicine specialist would bring together and coordinate the individual links of the specialist medical epidemiological state compels for the new standards to be drawn up regarding the comprehensive care provided to the cancer patients, including the changes in the pre graduation and postgraduation training of doctors, nurses and public health specialists, the development of academic oncology as well as the establishment of palliative and hospice care centers. At each one of those phases internal medicine specialists play a key role, they educate students, doctors, and nurses, they diagnose the majority of cancer types, they treat many patients with complications after chemotherapy and radiotherapy, they work at palliative and hospice care centers.
From the perspective of over 11 years of managing the oncology and hematology ward at a multidisciplinary hospital, I notice major benefits for the cancer patients coming from the thorough internist education of medical personnel. My fellow doctors from the clinic, which I have the honor to be managing, had first become internal medicine specialists and only then they completed clinical oncology or hematology specialty. Thus, they acquired the knowledge and competency in diagnosing and treating many additional diseases with which the today's cancer patient comes to the oncologist. The patient who had suffered a heart attack, with a stable coronary heart disease, hypertension, diabetes, chronic non specific bronchopulmonary disease, cirrhosis, pancreatitis, renal failure, Hashimoto thyroiditis, Cushing syndrome, etc. is not a "bugaboo" of our oncology center. The work at a multidisciplinary hospital certainly comes with the comfort of being able to consult difficult internist cases with doctors of other specialties. Still, the basis for such consultations is the knowledge and competency of my internal medicine specialists. Here is the example. The patient with advanced hepatocellular carcinoma (HCC), male, 66 years old, treated with an antiangiogenic drug whose toxicity profile included the induction of hypertension and thromboembolic complications. During the subsequent visit, the patient presented with the signs of an attack of angina pectoris, the immediate electrocardiography showed a non -ST -segment elevation acute coronary syndrome. The patient was transferred to the Clinical Department of Invasive Cardiology of the Central Clinical Hospital of the Ministry of the Interior and Administration (CSK MSWiA) where he underwent a coronary catheterization and a percutaneous transluminal coronary angioplasty (PTCA). During the subsequent stay in the Clinical Department of Oncology and Hematology of CSK MSWiA, the internal medicine and clinical oncology specialist established that the cause of the cardiological disorders was coronary atheromatosis and not the toxicity of the antiangiogenic drug and since the danger of a heart attack had been obviated thanks to the PTCA, then the patient could continue the oncological treatment with this drug. Thanks to such an approach, the patient lived for 2 more years taking the antiangiogenic drug and he died as a result the National Health Fund should bring about the desired results.
In the past the dawn, currently the dusk for the specialists of internal medicine only. Thus, it is high time we took action that will bring about the change in the perception of this situation and therefore the change from dusk till dawn. This phrase reminds us of a famous Robert Rodriguez and Quentin Tarantino movie from 1996 where the main characters survive the somber dusk and together with the coming of dawn they enter the path leading to the renaissance of positive values. I have a lot of appreciation for the initiative of those who are involved in guiding the internal medicine from dusk till dawn, that is the Polish Society of Internal Medicine, the Editorial Team of the Polish Archives of Internal Medicine (Polskie Archiwum Medycyny Wewnętrznej -Pol Arch Med Wewn), the National Consultant and the Regional Consultants in Internal Medicine and all doctors who took it to the heart to improve the social perception and the professional status of the internal medicine specialist. Coordinating the activities of all those persons and broadly understood cooperation with other scientific societies and doctors of other specialties should result in securing a uniform and exhaustive viewpoint that would be presented to the Minister of Health before the final decisions are taken regarding the changes within the health care system that are to be implemented at the beginning of 2018. 3 The Supreme Medical Council, 2015 report. http://www.nil.org.pl/ aktualnosci/lekarze-specjalisci-i-lekarze-dentysci-specjalisci-sytuacja--demograficzna.
care, cooperating with other specialists, especially with the geriatric and family medicine specialists.
The average age of a Polish practicing doctor is 49.5 years 1 and the average age of a specialist, 54.5 years (according to Romuald Krajewski 2 ). The number of practicing doctors is decreasing in the age group of 61-65 years, the same as regards specialists. 3 It means that within the 2 first decades of the 21st century, the growing number of cancer patients in Poland will be "faced" with the decreasing number of doctors, and in particular specialists. Therefore, there is a danger of significant limitations as regards the access to medical services for the patients, in particular cancer patients, and within a relatively short period of time. The report prepared by the Polish Chamber of Physicians and Dentists regarding physicians and dentists grouped by the field and the degree of specialization showed that as of 31 August 2016 in Poland there are 18 399 practicing internal medicine specialists, 450 practicing hematologists, and 816 practicing oncologists 1 . Just a brief look at the afore -mentioned data allows us to draw a conclusion that the number of hematology and clinical oncology specialists is too low to provide optimal medical care for the cancer patients in Poland. That is why internal medicine specialists constitute this professional group which is truly predisposed to help reduce the personnel shortage and treat cancer patients, both hematologically and in the case of solid tumors. Allowing internal medicine specialists to provide professional care for the cancer patients (solid tumors, leukemia and lymphoma, myeloma and associated monoclonal gammopathies, myeloproliferative syndrome and myelodysplastic syndrome) requires certain regulations and the changing of contracts concluded by the National Health Fund with the providers of oncological and hematological services. An internal medicine specialist working at an oncology or hematology ward for at least a year could receive a skills certification and in this way become authorized to independently conduct the oncology therapy and to provide medical services at the oncology or hematology clinic. Such a solution would reduce the shortage of clinical oncology and hematology specialists. Nevertheless, improving the access to medical services regarding oncology and hematology would require increasing the value of contracts which a given hospital and a clinic obtain from the Regional Department of the National Health Fund.
Undoubtedly, it is worth it to take action aimed at restoring the prestige once held by an internal medicine specialist. Coordinating the activities of the Polish Society of Internal Medicine with the activities of other scientific societies, like for example the Polish Society of Oncology, the Polish Society of Hematology and Transfusion Medicine, and the Polish Chamber of Physicians and Dentists together with the Regional Medical Chambers, supported by a proper policy of the Ministry of Health and the actions of hospicyjnej. Na każdym z tych etapów kluczową rolę odgrywają lekarze interniści -prowadzą dydaktykę dla studentów, lekarzy i pielęgniarek, rozpoznają większość nowotworów, leczą wielu chorych z powikłaniami po chemioterapii i po radioterapii, pracują w ośrodkach medycyny paliatywnej i hospicjach.
Z perspektywy ponad 11 -letniego kierowania oddziałem onkologicznym i hematologicznym w szpitalu wieloprofilowym dostrzegam ogromne korzyści, jakie chorym na nowotwory daje gruntowne wykształcenie internistyczne personelu medycznego. Koleżanki i koledzy lekarze z kliniki, którą mam zaszczyt kierować, zanim uzyskali specjalizacje z onkologii klinicznej lub hematologii, wpierw zostali specjalistami chorób wewnętrznych. Nabyli więc wiedzę i kompetencje w rozpoznawaniu i leczeniu wielu innych chorób, z którymi dziś zgłasza się do onkologa pacjent chory na nowotwór. Pacjent po zawale serca, ze stabilną chorobą wieńcową, z nadciśnie-niem tętniczym, cukrzycą, przewlekłą nieswoistą chorobą oskrzelowo -płucną, marskością wątroby, zapaleniem trzustki, niewydolnością nerek, chorobą Hashimoto, zespołem Cushinga itd. nie jest "postrachem" naszego ośrodka onkologicznego. Praca w szpitalu wieloprofilowym oczywiście daje nam komfort konsultacji trudnych przypadków internistycznych u lekarzy innych specjalności. Tym niemniej, podstawą do owych konsultacji jest wiedza i kompetencje moich specjalistów chorób wewnętrznych. Oto przykład. Chory na zaawansowanego raka wątrobowokomórkowego, mężczy-zna w wieku 66 lat, był leczony lekiem antyangiogennym, którego profil toksyczności obejmował indukowanie nadciśnienia tętniczego i powikłań zakrzepowo -zatorowych. Podczas kolejnej wizyty chory miał objawy napadu dławicy piersiowejwykonany natychmiast elektrokardiogram wykazał ostry zespół wieńcowy bez uniesienia odcinka ST. Pacjent został przeniesiony do Kliniki Kardiologii Inwazyjnej CSK MSWiA, gdzie wykonano Specjalista chorób wewnętrznych! Kiedy otrzymywałem dyplom lekarza z rąk Rektora Akademii Medycznej w Warszawie, Profesora Jana Nielubowicza, osiągnięcie takiego statusu zawodowego było marzeniem moim i wielu moich Koleża-nek i Kolegów. Przez lata specjalista chorób wewnętrznych był symbolem najwyższego poziomu w wykonywaniu zawodu lekarza -po prostu umiał leczyć wszystkie choroby, które dotknęły narzą-dów wewnętrznych człowieka. W ciągu 30 lat wykonywania zawodu lekarza miałem okazję zaobserwować ogromy postęp, jaki dokonał się w medycynie, ale też postępujący spadek prestiżu i zaufania społecznego do lekarza, który jest specjalistą tylko chorób wewnętrznych. W tym czasie dokonały się zmiany w systemie szkolenia lekarzy, a także zmiany w systemie finansowania świad-czeń medycznych. W obu tych obszarach preferuje się wąskoprofilową specjalizację. Zarówno w Polsce, jak i na świecie obserwuje się postępujące starzenie się społeczeństw oraz wzrost liczby chorób przypadających na jednego człowieka. Od kilku dekad obserwujemy epidemię chorób układu sercowo -naczyniowego oraz chorób nowotworowych. Epidemiolodzy szacują, że w ciągu najbliższych 50 lat nowotwory staną się pierwszą przyczyną umieralności w Polsce. Już teraz w naszym kraju rokrocznie rozpoznaje się ponad 150 tysięcy nowych zachorowań na nowotwory, z czego ponad 90 tysięcy chorych umiera w ciągu tego samego roku, a liczba zgonów z roku na rok rośnie. Głównymi zbójcami Polek i Polaków są obecnie: rak płuca, rak jelita grubego, rak piersi, rak prostaty, ale też raki żołądka, trzustki, jajnika oraz rejonu głowy i szyi. Ten stan epidemiologiczny nakazuje wypracowanie nowych standardów w kompleksowej opiece nad chorymi na nowotwory, począwszy od zmian w szkoleniu przeddyplomowym i podyplomowym lekarzy, pielęgniarek i specjalistów zdrowia publicznego, poprzez rozwój onkologii akademickiej, po tworzenie ośrodków medycyny paliatywnej i opieki
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